Sharechat Logo

Illness sees Fonterra chair John Wilson replaced by John Monaghan

Friday 27th July 2018

Text too small?

Fonterra Cooperative chair John Wilson has stood down from the role heading the country's largest dairy processor with immediate effect as he recovers from a "serious health scare".

Wilson, who has undergone a significant surgery in the past month and requires ongoing treatment, will remain a Fonterra director until the cooperative’s annual meeting in November, when he will retire from the board, the Auckland-based company said in a statement. Fonterra's board has selected John Monaghan, who has been a director on the board since 2008, as the cooperative’s new chair. 

Wilson and outgoing Fonterra chief executive Theo Spierings have faced criticism in recent times following the poor performance of the cooperative's 18.8 percent investment in Chinese infant milk formula company Beingmate and lacklustre earnings growth. Spierings announced in March that he would leave the position in the course of this year, and pressure has been mounting for Wilson to also step down.

Fonterra said today that Monaghan has been closely involved in the process to appoint a new chief executive and will now lead that process with the full involvement of the board.

Monaghan grew up on a dairy farm and has farming interests in the Wairarapa and Otago. He has served on multiple Fonterra committees, chairing several of them, and taken a lead role in representing Fonterra’s interests on customer visits and global trade issues and has strong networks both domestically and internationally with key stakeholders, the company said. 

Wilson said the decision to stand down as chair had been difficult but was ultimately in the best interests of the cooperative.

“I have made a very good recovery and am well but will need on-going treatment," Wilson said in a statement. "Governance roles are incredibly rewarding, but equally demanding on the individual and their families. Continuing as chairman when I cannot put my full energy and attention into the role is not appropriate.”

Units in the Fonterra Shareholders' Fund, which give investors exposure to Fonterra's earnings, last traded at $5.16 and have dropped 14 percent over the past year


  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

MARKET CLOSE: NZ shares fall as investor uncertainty weighs on exporters; F&P Health, A2 drop
NZ dollar drops below US68c on plan to up bank capital
Noel Leeming fined $200,000 for misleading consumers
Big four banks face stiffer capital requirements from RBNZ
Infratil signals A$50m investment in Canberra Data Centres
Govt provides $2.5 mln to develop Opotiki aquaculture
Labour co-ordinator role may alleviate kiwifruit labour shortage
NZ manufacturing activity chugs along in November
Australia's GWA lobs in $118M bid for Methven
Govt leaves door open for higher emissions price cap

IRG See IRG research reports